Althea Group

Dieta, Inc. is a San Francisco-based company founded in 2018 that develops an application focused on managing digestive health, particularly for individuals suffering from Irritable Bowel Syndrome (IBS). The app allows users to input detailed information about their food intake, physical activity, medications, and digestive health metrics. By utilizing machine learning algorithms and data science techniques, Dieta's platform analyzes this data to provide personalized insights and recommendations aimed at preventing digestive issues and alleviating symptoms associated with IBS. This innovative approach assists users in improving their overall quality of life by offering tailored guidance based on their unique health profiles.

Kegg is a health technology company based in San Francisco, California, founded in 2017. It specializes in developing a two-in-one device that combines fertility tracking with pelvic floor exercises. Kegg's primary product is an innovative fertility tracker that enhances the chances of natural conception by accurately detecting the fertile window and ovulation up to seven days in advance. The device achieves this by analyzing changes in cervical fluid, providing essential data that was previously difficult to obtain. This information empowers women to make informed decisions regarding their reproductive health, thereby improving diagnosis, monitoring, and treatment options.

Oisin Biotechnologies is a biotechnology company based in Seattle, Washington, founded in 2014, that specializes in developing therapies to address age-related diseases by targeting senescent cells. The company utilizes its SENSOlytics platform, which focuses on precisely identifying and clearing these dysfunctional cells based on their DNA expression, distinguishing them from healthy cells. Oisin is advancing a range of therapeutic programs, including one aimed at reducing frailty by promoting muscle growth without the need for exercise, as well as another that targets fat cells. The company employs a novel, non-viral delivery system for its genetic medicines, which enhances the distribution of both DNA and RNA components, thereby addressing multiple factors contributing to age-related conditions. Recent studies indicate that eliminating senescent cells can mitigate aging-related health issues and potentially extend lifespan.

OncoSenX, Inc. is a preclinical-stage oncology company based in Seattle, Washington, focused on developing therapeutics that target cancer cells based on genetic profiles. The company has created a tumor-killing platform that utilizes a proprietary lipid nanoparticle for effective cellular delivery of a highly selective DNA payload. This innovative therapy aims to treat solid tumors by delivering plasmid DNA designed to induce apoptosis, or programmed cell death, in cancerous cells. By selectively targeting cells based on their transcriptional activity, OncoSenX offers a less invasive and more precise approach to cancer treatment, which may result in fewer side effects for patients. Established in 2017, the company seeks to provide improved therapeutic options for patients, doctors, and medical professionals dealing with complex cancer cases.

Headspace is a digital health platform established in 2010 and headquartered in Santa Monica, California, that specializes in guided meditation and mindfulness training. It offers a vast library of content, recognized as one of the most comprehensive secular programs in this field, accessible via mobile and tablet applications. Users can engage in mindfulness practices through various features, including health videos and chat options, which also facilitate access to free meditation sessions. Headspace Health, an extension of the brand, focuses on mental health and well-being, partnering with over 2,500 companies and health plans to provide services that include meditation, mindfulness, coaching, therapy, and psychiatry. Notable partners include major organizations such as Starbucks, Adobe, Delta Air Lines, ViacomCBS, Cigna, and Kaiser Permanente.

Developer of a gene delivery platform intended to enable the development and commercialization of vaccines and therapeutics to prevent and treat infectious diseases. The company's proprietary breakthrough technology can rapidly develop vaccines and therapeutics to fight COVID-19 and other emerging contagions, enabling the pharmaceutical industry to accelerate the discovery, clinical development, and manufacture of vaccines and therapeutics.

FLX Distribution operates a digital marketplace designed to connect asset managers with experienced distribution professionals. Founded in 2019 and based in Basking Ridge, New Jersey, with an additional location in New York City, FLX Distribution leverages technology to enhance financial services distribution solutions. Its platform, known as FLX Value Proposition, provides a member-structured environment that facilitates access, education, and data sharing among stakeholders in the asset management sector. By integrating principles of the sharing economy, FLX Distribution aims to improve the efficiency and effectiveness of business operations for all participants in the financial services industry.

RXTransparent is a software-as-a-service (SAAS) platform tailored for healthcare providers, aimed at enhancing visibility and efficiency in the drug supply chain. The platform offers solutions that enable users to monitor product inventory transparently, ensure regulatory compliance, and leverage supply chain analytics. By providing these tools, RXTransparent helps healthcare organizations manage their supply chains more effectively, improving operational performance and reducing risks associated with drug supply management.

Truelytics, based in Boston, is a B-to-B enterprise SaaS startup that specializes in providing an Advisor Transition Management platform. This innovative platform serves wealth management, insurance, and tax firms by offering a comprehensive, data-driven approach to managing business transitions. Truelytics enables these enterprises to analyze their business performance and recruitment strategies, delivering actionable insights and key performance indicators. By focusing on efficiency, the platform helps firms attract, grow, and retain advisory businesses while minimizing the time and costs associated with transitions.

Alt Legal, Inc. is a legal technology company based in New York that specializes in software for managing intellectual property (IP) filings. Founded in 2013 and previously known as Plainlegal, Inc., the company offers a suite of cloud-based tools that simplify the preparation and management of global IP filings. Its docketing software automatically updates case statuses and deadlines, collects essential client information, and generates IP filings with ease. Alt Legal's solutions are utilized by a range of clients, including Am Law firms, IP boutiques, and in-house legal departments, enabling them to efficiently handle thousands of filings each day.